Advancing excellence in laboratory medicine for better healthcare worldwide

Task Force Corporate Members (TF-CM)

Membership

Name Position Country Term Time in Office
Tricia Ravalico Chair/ABBOTT US 1st 2021 01 - 2023 12
Alessandro Ortisi Secretary/SIEMENS Healthineers IT 1st 2021 04 - 2023 12
Jean-Sébastien Blanchet  Member/BECKMAN COULTER FR 2nd  2022 01 - 2024 12
Vincent Chen Member/SNIBE CN 1st 2021 04 - 2023 12
Brendan Meyer Member/BECTON DICKINSON UK 1st 2021 04 - 2023 12
Andy Quintenz Member/BIO-RAD US 1st 2022 04 - 2024 12
Joseph Passarelli EB Corporate Representative/ROCHE US 1st 2021 01 - 2023 12


 


 

 


 TF-CM Meeting in person in Munich at the EuroMedLab Congress

 April 11 2022

From left to right - top to bottom: 

Michael Rottmann  - SD Corporate Member Rep/Roche; Tricia Ravalico - Chair/Abbott; Alessandro Ortisi - Secretary/Siemens Healthineers; Joseph Passarelli - Executive Board Corporate Member Rep/Roche - Jean-Sébastien Blanchet - Member/Beckman Coulter.


 

Aim

The aim of IFCC TF-CM is to enable Corporate Members to make significant and growing contributions to the activities of IFCC, and to elevate key topics and priorities for the betterment of industry collaborations, laboratory medicine and health care.

Objectives

  • To assist IFCC in promotion of science, innovation, and advancement of the essential contribution of laboratory medicine to health care
  • To facilitate discussion among Corporate Members and identify common topics of interest and/or concern
  • To improve the engagement of Corporate Members with the IFCC
  • To serve as the “voice of industry” and be more accessible to all IFCC teams and leadership, enabling a more diverse understanding and appreciation of needs among corporate members and the IFCC
  • To increase awareness with other Corporate Members of IFCC TF-CM and to encourage their participation in IFCC activities 

Accountability

The TF-CM will report directly to the IFCC Executive Board. The Corporate Representative of the Executive Board will be a liaison to the EB while serving as a member of TF-CM. The TF-CM will prepare reports to the Executive Board on meeting outcomes.

Background

The IFCC Task Force Corporate Members (TF-CM) was approved by the IFCC Executive Board and established in 2019 in order to strengthen the collaboration between IFCC and its Corporate Members. Similar to other task forces, the TF-CM reports directly to the IFCC Executive Board. The TF-CM consists of the chair and 6 other members, including the secretary, the Corporate Representative at the IFCC Executive Board, and 3 other members. Members are elected by the IFCC EB from nominations from the corporate representatives. The corporate representatives from each of the other divisions are also invited and encouraged to attend the TF-CM meetings. Memberships on the TF-CM are for 3 years with the possibility of extension for an additional 3 years.

Areas of Focus

  • The voice of corporate members within IFCC
  • High impact and frequency of conferences/congresses
  • Growth and sustainability of corporate members
  • Effective, timely and enhanced communications among IFCC, Conference Organizing Secretariat, and Corporate Members
  • Industry needs for IFCC involvement with regulators and clinical societies

 

Read the TF-CM article  extracted from the IFCC e-News-March 2021


  

 

List of Corresponding Members, nominated by Companies

 

 
Name Company
Jan Gorka DiaSys Diagnostic Systems
Gavin Tu Maccura Biotechnology
Yan Liu Mindray
Nadav Kaufman Ortho Clinical Diagnostics
Anne Skurup Radiometer Medical ApS
Maurizio Gramegna Technogenetics

 


 

Membership 

 

Chair

Tricia RAVALICO
Director, Scientific Leadership and Education
Medical and Scientific Affairs
Core Diagnostics
Abbott
100 Abbott Park Road
CP-01-5
Abbott Park, IL 60064
USA
e-mail: Tricia.Ravalico@abbott.com

Secretary

Alessandro ORTISI

Associate Director / Global Clinical Marketing
Laboratory Diagnostics
SHS LD M&S CLS CM CA
Siemens Healthineers
Via Vipiteno, 4
20128 Milano
Italy
e-mail: alessandro.ortisi@siemens-healthineers.com



 

 

 

Members 

Jean-Sébastien BLANCHET
Beckman Coulter Diagnostics
Director Medical and Scientific
France
e-mail: jblanchet@beckman.com

Vincent CHEN
Global Marketing Manager
SNIBE
No.23, Jinxiu East Road
Pingshan District
518122 Shenzhen
P.R. China
e-mail: vincent.chen@snibe.com 

Brendan MEYER
Senior Manager, Medical Affairs Europe
Integrated Diagnostic Solutions
Becton Dickinson Life Sciences
Winnersh
UK
e-mail: Brendan.Meyer@bd.com

 

T. Andrew QUINTENZ
Bio-Rad Laboratories
Assoc Director, Quality Systems Market Development
Clinical Diagnostics Group
9500 Jeronimo Road
Irvine CA 92618-2017
USA
e-mail: andy_quintenz@bio-rad.com

 

 

EB Corporate Representative

Joseph PASSARELLI
Scientific Relations, Research and Development
Roche Diagnostics Corporation
9115 Hague Road, PO Box 50416
Indianapolis, Indiana 46250-0416 - USA
Tel: +1 317 521 4206
Fax: +1 317 521 2324
Mobile: +1-317-625-7810
E-mail: joseph.passarelli@roche.com

 

 

 
Website developed by Insoft